Harold Mastalerz

1.0k citations

37 papers · 570 indexed · h-index 13

Organic Chemistry top 10%
Molecular Biology
Oncology
Radiology, Nuclear Medicine and Imaging top 10%
Pharmacology

Co-authors: David Willner Dalton King Pamela A. Trail Gene M. Dubowchik Sandra J. Hofstead Shirley J. Lasch Raymond A. Firestone Marcel Ménard
Topics: Synthetic Organic Chemistry Methods (7 papers)Synthesis of β-Lactam Compounds (6 papers)HER2/EGFR in Cancer Research (6 papers)
Cited by: Organic Chemistry Oncology Radiology, Nuclear Medicine and Imaging
Journals: Journal of the American Chemical Society Clinical Cancer Research Journal of Medicinal Chemistry
Partner nations: United States Germany Poland

In The Last Decade

Harold Mastalerz

36 papers receiving 534 citations

Peers

Countries citing papers authored by Harold Mastalerz

Since Specialization

Citations

This map shows the geographic impact of Harold Mastalerz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Mastalerz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Mastalerz more than expected).

Fields of papers citing papers by Harold Mastalerz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Mastalerz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Mastalerz. The network helps show where Harold Mastalerz may publish in the future.

Co-authorship network of co-authors of Harold Mastalerz

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Mastalerz. A scholar is included among the top collaborators of Harold Mastalerz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Mastalerz. Harold Mastalerz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Kurt Zimmermann,(unknown),Harold Mastalerz,Walter L. Johnson,Guifen Zhang,Qingjie Liu,Douglas G. Batt,Louis J. Lombardo,(unknown),George L. Trainor,John S. Tokarski,Matthew V. Lorenzi,Dan You,Marco M. Gottardis,Jonathan Lippy,Javed Khan,John S. Sack,Ashok V. Purandare	10
2	The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor 2014 ·Acta Crystallographica Section F Structural Biology Communications ·Susan E. Kiefer,ChiehYing Chang,(unknown),Mian Gao,Dianlin Xie,Yaqun Zhang,Guifen Zhang,Martin B. Gill,Harold Mastalerz,Lorin A. Thompson,Angela Cacace,S. Sheriff	20
3	Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases 2010 ·Bioorganic & Medicinal Chemistry Letters ·Brian E. Fink,Derek Norris,Harold Mastalerz,Ping Chen,Bindu Goyal,Yufen Zhao,Soong‐Hoon Kim,Gregory D. Vite,Francis Y. Lee,Hongjian Zhang,Simone Oppenheimer,John S. Tokarski,Tai W. Wong,Ashvinikumar V. Gavai	23
4	Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases 2007 ·Bioorganic & Medicinal Chemistry Letters ·Harold Mastalerz,Ming Chang,Ashvinikumar V. Gavai,Walter L. Johnson,David R. Langley,Francis Y. Lee,Punit Marathe,Arvind Mathur,Simone Oppenheimer,(unknown),John S. Tokarski,Gregory D. Vite,Dolatrai M. Vyas,Henry Ν. C. Wong,Tai W. Wong,Hongjian Zhang,Guifen Zhang	24
5	Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling 2006 ·Clinical Cancer Research ·Tai W. Wong,Francis Y. Lee,Chiang Yu,Feng Luo,Simone Oppenheimer,Hongjian Zhang,Richard Smykla,Harold Mastalerz,Brian E. Fink,John T. Hunt,Ashvinikumar V. Gavai,Gregory D. Vite	65
6	New dual inhibitors of EGFR and HER2 protein tyrosine kinases 2005 ·Bioorganic & Medicinal Chemistry Letters ·Brian E. Fink,Gregory D. Vite,Harold Mastalerz,John F. Kadow,Soong‐Hoon Kim,Kenneth J. Leavitt,(unknown),(unknown),Toomas Mitt,Tai W. Wong,John T. Hunt,Dolatrai M. Vyas,John S. Tokarski	37
7	The discovery of BMS-275183: an orally efficacious novel taxane 2003 ·Bioorganic & Medicinal Chemistry ·Harold Mastalerz,(unknown),Craig R. Fairchild,Steven Hansel,Walter L. Johnson,John F. Kadow,Byron H. Long,William C. Rose,(unknown),(unknown),(unknown),Guifen Zhang,Mary Zoeckler,Dolatrai M. Vyas	39
8	Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages 2002 ·Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik,(unknown),Harold Mastalerz,Michael Walker,Raymond A. Firestone,Dalton King,Sandra J. Hofstead,David Willner,Shirley J. Lasch,Pamela A. Trail	30
9	Synthesis of a hybrid analog of the esperamicin and dynemicin cores 1996 ·Tetrahedron Letters ·Harold Mastalerz,Terrence W. Doyle,John F. Kadow,Dolatrai M. Vyas	2
10	The effect of propargylic substitution on the activation and aromatization of enediynes 1994 ·Bioorganic & Medicinal Chemistry Letters ·Mark D. Wittman,John F. Kadow,(unknown),(unknown),Harold Mastalerz,Dolatrai M. Vyas,William C. Rose,(unknown),Nada Zein	2
11	Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems 1992 ·Journal of Medicinal Chemistry ·Harold Mastalerz,(unknown),Edward H. Ruediger,J Fung-Tomc	12
12	The synthesis, antibacterial, and .BETA.-lactamase inhibitory activity of a novel asparenomycin analog. 1992 ·The Journal of Antibiotics ·(unknown),Harold Mastalerz,Marcel Ménard,J Fung-Tomc,Elizabeth Gradelski	4
13	The Synthesis of a 6-Carbamoyl Substituted Carbapenem 1991 ·Heterocycles ·Harold Mastalerz,(unknown)	6
14	The synthesis of an asparenomycin analog 1991 ·Tetrahedron Letters ·(unknown),Harold Mastalerz,Marcel Ménard	4
15	An examination of O-2-isocephems as orally absorbable antibiotics 1988 ·Journal of Medicinal Chemistry ·Harold Mastalerz,Marcel Ménard,(unknown),(unknown),J Fung-Tomc,R E Kessler,(unknown)	40
16	A general enantioselective O-2-isocephem synthesis 1987 ·Journal of the Chemical Society Chemical Communications ·Harold Mastalerz,(unknown)	11
17	A 2-methylthio-3,5-diaryl-1,3,4-thiadiazolium cation; its reactions, and further exploration of the chemistry of 2-alkyl-3,5-diaryl-1,3,4-thiadiazolium cations 1987 ·Canadian Journal of Chemistry ·Harold Mastalerz,Taj Mohammad,Martin S. Gibson	5
18	Routes to 3-aryl-5-phenyl-2-thioacylmethylene-2H-1,3,4-thiadiazolenes 1981 ·Journal of the Chemical Society Perkin Transactions 1 ·Harold Mastalerz,Martin S. Gibson	9
19	Acylation of N′-arylbenzothiohydrazides and of their N′-acyl-derivatives; 2-acylalkylidene-3-aryl-5-phenyl-2H-1,3,4-thiadiazolenes and related compounds 1981 ·Journal of the Chemical Society Perkin Transactions 1 ·(unknown),Arthur J. Elliott,Sham S. Gandhi,Martin S. Gibson,Harold Mastalerz,(unknown)	3
20	19-Hydroxy-steroids. Part 7. Boron trifluoride-catalysed reactions of 19-hydroxy- and 19-acetoxy-5,6-epoxy-steroids 1981 ·Journal of the Chemical Society Perkin Transactions 1 ·Harold Mastalerz,Peter Morand	6

About Harold Mastalerz

Harold Mastalerz is a scholar working on Molecular Medicine, Organic Chemistry and Pharmacology, having authored 37 papers that have together received 570 indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (7 papers), Synthesis of β-Lactam Compounds (6 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Organic Chemistry (253 citations), Oncology (218 citations) and Radiology, Nuclear Medicine and Imaging (136 citations). Harold Mastalerz has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include David Willner, Dalton King, Pamela A. Trail, Gene M. Dubowchik, Sandra J. Hofstead, Shirley J. Lasch, Raymond A. Firestone, Marcel Ménard, Tai W. Wong and Gregory D. Vite. Their work appears in journals such as Journal of the American Chemical Society, Clinical Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact